Foley Represents AltheaDx in Acquisition by Castle Biosciences

Foley & Lardner LLP announced today that it represented AltheaDx, Inc., a mental health diagnostics company, in its recent acquisition by Castle Biosciences, Inc., a company improving health through innovative tests that guide patient care. AltheaDx is a commercial-stage molecular diagnostics company specializing in the field of pharmacogenomics (PGx) testing services that are focused on […]